drugset / Trial / NCT07329907
Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic
RandomizedParallel-groupSingle-blindTreatment
Summary
Objective: To compare the efficacy, safety, and recurrence rates of topical salicylic acid/lactic acid (SA/LA) monotherapy (Group A), intralesional Candida antigen (CA) monotherapy (Group B), and their combination (Group C) for the treatment of warts.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-06-01
- Completion
- 2024-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Candida antigen | Vaccine | 0.1 ml | Other |
| Comparator | Candida antigen | Vaccine | 0.3 ml | Other |
| Comparator | Lactic Acid | Other / unclassified | 16 % | Topical |
| Comparator | salicylic acid | Small molecule | 40 % | Topical |